STRYKER CORP (SYK) Overview
Healthcare • NYSE • CIK 0000310764
Loading...
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Market Cap
$118.95B
P/E (TTM)
32.8x
Rev Growth (TTM)
+7.9%
Net Margin (TTM)
13.8%
FCF Yield (TTM)
3.8%
FCF Margin (TTM)
17.4%
Figures as of September 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.
8-KNov 20262026-11-09source
10-Q2026 Q32026-10-30source
8-KEarnings2026-10-29source
8-KOct 20262026-10-06source
10-Q2026 Q22026-07-31source
What your agent reads
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q3
18 days ago
8-K releaseRevenue
$6.52B
+7.6%
Net Income
$753.00M
-12.3%
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$4.6B
Q3 '26
$1.2B+16%
Q2 '26
$1.1B+155%
FCF Margin
TTM17.4%
Q3 '2618.8%+17%
Sector: 3.3%Top 25%
OCF Margin
20.7%
OCF/NI1.50x
CapEx Coverage
6.2x
FCF Yield3.8%
FCF Growth (3Y)+21%
Cash Conversion Cycle
–
DSO: 52+DIO: 218−DPO: –
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder Yield
TTM1.1%
Div Yield1.1%
+Buybacknot disclosed
Dividend & Payout Metrics
Dividend Yield (TTM)1.1%
FCF Payout Ratio29.3%
Free Cash Flow (TTM)$4.6B
Capital Return / FCF29.1%
Shares Outstanding (YoY)-0.4%↓ Buyback
Est. Dividends Paid (TTM)$1.3B
Buyback data not disclosed in this company's filings.
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
32.8x
Volatile
8Q: 41.7x-2942%
Valuation Lenses
Earnings
32.8x
vs – sector
Cash Flow
28.6x
EV/FCF vs –
Growth-Adj
1.4xPEG
Fair for growth
Quality-Adj
3.3P/E per %ROIC
ROIC: 10.0%
Shareholder Returns
Dividend
1.1%
Buyback
–
Total Yield
1.1%
Market Cap$118.95B
EV$130.60B
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
65.3%
Operating
20.7%
Top 25% in sector
Net
13.8%
Margins Unknown
Return on Invested CapitalTTM
10.0%
Stable
+0.0% YoY8Q: 9.3%+2.9%
P25MedianP75
75th pctl (med: -8.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.6%
8Q: 13.7%
Asset Turnover
0.56x
8Q: 0.54x
Leverage (1+D/E)
1.64x
D/E: 0.64x
DuPont: 13.3% ≈ 10.0% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
6.74x
8Q:6.69x
-59.8%
Invested Cap Turn
0.72x
8Q:0.71x
-6.0%
CapEx Intensity
2.4%
8Q:2.2%
CapEx/Depreciation
0.54x
FCF vs Net Margin Gap+3.6 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 1.7x
Net Debt / EBITDA
1.7xNet Debt: $11.66B
Interest Coverage
9.3x
+Strong interest coverage: 9.3x
Leverage Metrics
Debt-to-Equity
0.64x
Balance sheet risk & solvency analysis
Related Research
3 related posts